Join The Michael J. Fox Foundation for the Parkinson's Unity Walk as it celebrates 30 years on April 27 in New York City's Central Park for a day of activities to celebrate, learn and connect, all while raising critical funds for a cure - 100 percent of donations support research and public policy priorities.

1010 WINS Sharon Barnes-Waters spoke to Dr. Mark Frasier, Michael J. Fox Foundation's Chief Scientific Officer, about the foundations breakthrough research that identified a biomarker for Parkinson's disease which may be able to indicate disease before typical symptoms appear. 

Join The Michael J. Fox Foundation for the Parkinson's Unity Walk as it celebrates 30 years on April 27 in New York City's Central Park for a day of activities to celebrate, learn and connect, all while raising critical funds for a cure - 100 percent of donations support research and public policy priorities.
1010 WINS Sharon Barnes-Waters spoke to Dr. Mark Frasier, Michael J. Fox Foundation's Chief Scientific Officer, about the foundations breakthrough research that identified a biomarker for Parkinson's disease which may be able to indicate disease before typical symptoms appear.

All News, All The Time. Updated daily from the 1010 WINS newsroom.

1010 WINS News Update

Special features and reports from 1010 WINS. 

Special features and reports from 1010 WINS.&nbsp;

1010 WINS - EXTRAS

1010 WINS Sharon Barnes-Waters interviwed Dr. Mark Frasier, Michael J. Fox Foundation's Chief Scientific Officer, about the foundations breakthrough research that identified a biomarker for Parkinson's disease which may be able to indicate disease before typical symptoms appear.

Advertisement